PTX:ASX
Prescient Therapeutics Ltd
A$0.066
0.00%
(0.00) 1D
Oct 2, 5:00:00 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Open
A$0.06
High
A$0.07
Low
A$0.06
Mkt. cap
75.49M
Avg. vol.
1.17M
Volume
1.35M
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
Open
A$0.06
High
A$0.07
Low
A$0.06
Mkt. cap
75.49M
Avg. vol.
1.17M
Volume
1.35M
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
News stories
From web sources and news partners
AOL.com
·
12 minutes ago
History Says Stocks Typically Fall After a Fed Hike Cycle Begins -- Then Gain 6.8% Within a Year. Here's My Plan.
24/7 Wall St.
·
34 minutes ago
Why Pay to Own U.S. Stocks? This Zero-Fee ETF Is Beating the S&P 500
azcentral.com and The Arizona Republic
·
1 hour ago
Is a stock market correction coming? Most Americans think so
The Motley Fool
·
59 minutes ago
The S&P 500 Hasn't Looked This Cheap Based on a Popular Metric in Decades. Should You Buy Stocks Now?
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
FoundedMay 22, 1986
Headquarters-
SectorBiotechnology
Websiteptxtherapeutics.com